Cav3.2

1

Berecki G et al. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
Neuropharmacology, 2016 May 28 , 109 (49-58).

2

Long D et al. Identification of genetic variants associated with susceptibility to West Nile virus neuroinvasive disease.
Genes Immun., 2016 May 12 , ().

3

Voisin T et al. Genetic alteration of the metal/redox modulation of Cav3.2 T-type calcium channel reveals its role on neuronal excitability.
J. Physiol. (Lond.), 2016 Mar 2 , ().

4

Yang W et al. Cannabinoid receptor agonists modulate calcium channels in rat retinal müller cells.
Neuroscience, 2016 Jan 28 , 313 (213-24).

5

Hurtado R et al. Hyperpolarization-activated cation and T-type calcium ion channel expression in porcine and human renal pacemaker tissues.
J. Anat., 2016 Jan 25 , ().

6

Elíes J et al. Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: Emerging controversies concerning the role of H2 S in nociception.
J. Physiol. (Lond.), 2016 Jan 25 , ().

7

Makarenko VV et al. CaV3.2 T-type Ca2+ channels mediate the augmented calcium influx in carotid body glomus cells by chronic intermittent hypoxia.
J. Neurophysiol., 2016 Jan 1 , 115 (345-54).

8

Sakkaki S et al. A role of T-type calcium channels in tonic-clonic seizures as revealed by the anticonvulsant properties of the blocker TTA-A2.
Neuropharmacology, 2015 Oct 9 , ().

9

Butler MG et al. Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation.
Am. J. Med. Genet. B Neuropsychiatr. Genet., 2015 Oct 13 , ().

10

Fukami K et al. Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells.
Biochem. Pharmacol., 2015 Oct 1 , 97 (300-9).

11

Park SJ et al. Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.
Biochim. Biophys. Acta, 2015 Oct , 1848 (2092-100).

12

Siapich SA et al. Low concentrations of ethanol but not of dimethyl sulfoxide (DMSO) impair reciprocal retinal signal transduction.
Graefes Arch. Clin. Exp. Ophthalmol., 2015 Oct , 253 (1713-9).

13

Blesneac I et al. Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties.
Proc. Natl. Acad. Sci. U.S.A., 2015 Nov 3 , 112 (13705-10).

14

Harraz OF et al. CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries.
J. Gen. Physiol., 2015 May , 145 (405-18).

15

Felizola SJ et al. Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues.
Endocr. Pathol., 2015 May , 26 (119-28).

16

Curran J et al. Eps15 Homology Domain-containing Protein 3 Regulates Cardiac T-type Ca2+ Channel Targeting and Function in the Atria.
J. Biol. Chem., 2015 Mar 30 , ().

17

Neumaier F et al. Voltage-gated calcium channels: Determinants of channel function and modulation by inorganic cations.
Prog. Neurobiol., 2015 Mar 25 , ().

18

Zhang L et al. Lipopolysaccharides upregulate calcium concentration in mouse uterine smooth muscle cells through the T-type calcium channels.
Int. J. Mol. Med., 2015 Mar , 35 (784-90).

19

Monteil A et al. Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop.
J. Biol. Chem., 2015 Jun 26 , 290 (16168-76).

20

Elíes J et al. H2S does not regulate proliferation via T-type Ca2+ channels.
Biochem. Biophys. Res. Commun., 2015 Jun 12 , 461 (659-64).

21

Tompkins JD et al. Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.
Am. J. Physiol., Cell Physiol., 2015 Jun 1 , 308 (C857-66).

22

Enyeart JJ et al. Adrenal fasciculata cells express T-type and rapidly and slowly activating L-type Ca2+ channels that regulate cortisol secretion.
Am. J. Physiol., Cell Physiol., 2015 Jun 1 , 308 (C899-918).

23

Bladen C et al. 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.
Pflugers Arch., 2015 Jun , 467 (1237-47).

24

Wang G et al. CaV3.2 calcium channels control NMDA receptor-mediated transmission: a new mechanism for absence epilepsy.
Genes Dev., 2015 Jul 15 , 29 (1535-51).

25

Martinello K et al. Cholinergic afferent stimulation induces axonal function plasticity in adult hippocampal granule cells.
Neuron, 2015 Jan 21 , 85 (346-63).

26

Makarenko VV et al. CaV3.2 T-type Ca²⁺ channels in H₂S-mediated hypoxic response of the carotid body.
Am. J. Physiol., Cell Physiol., 2015 Jan 15 , 308 (C146-54).

27

Francois A et al. The Low-Threshold Calcium Channel Cav3.2 Determines Low-Threshold Mechanoreceptor Function.
Cell Rep, 2015 Jan 14 , ().

28

Cretoiu SM et al. Isolated human uterine telocytes: immunocytochemistry and electrophysiology of T-type calcium channels.
Histochem. Cell Biol., 2015 Jan , 143 (83-94).

29

Wang Q et al. [Effects of bisphenol A on voltage-dependent T-type calcium channels in mouse testis and epididymis, and the role of estrogen receptors].
Wei Sheng Yan Jiu, 2015 Jan , 44 (23-7).

30

Hamby AM et al. CaV3.2 KO mice have altered retinal waves but normal direction selectivity.
Vis. Neurosci., 2015 Jan , 32 (E003).

31

Liao P et al. Alternative splicing generates a novel truncated Cav1.2 channel in neonatal rat heart.
J. Biol. Chem., 2015 Feb 18 , ().

32

Bladen C et al. Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.
ACS Chem Neurosci, 2015 Feb 18 , 6 (277-87).

33

Hansen PB Functional importance of T-type voltage-gated calcium channels in the cardiovascular and renal system: news from the world of knockout mice.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2015 Feb 15 , 308 (R227-37).

34

Weaver EM et al. Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
Eur. J. Pharmacol., 2015 Feb 15 , 749 (20-31).

35

Männikkö R et al. Pharmacological and electrophysiological characterisation of hERG activator AZSMO-23.
Br. J. Pharmacol., 2015 Feb 12 , ().

36

Fukunaga K [Cognitive Function and Calcium. Cognitive improvement through T type calcium channel stimulation].
Clin Calcium, 2015 Feb , 25 (247-54).

37

Terada Y et al. Roles of Cav3.2 and TRPA1 channels targeted by hydrogen sulfide in pancreatic nociceptive processing in mice with or without acute pancreatitis.
J. Neurosci. Res., 2015 Feb , 93 (361-9).

38

Duckles H et al. Heme oxygenase-1 regulates cell proliferation via carbon monoxide-mediated inhibition of T-type Ca2+ channels.
Pflugers Arch., 2015 Feb , 467 (415-27).

39

Murakami-Nakayama M et al. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
J. Pharmacol. Sci., 2015 Feb , 127 (223-8).

40

Lv N et al. Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population.
Seizure, 2015 Aug , 30 (64-9).

41

Harraz OF et al. Genetic ablation of CaV3.2 channels enhances the arterial myogenic response by modulating the RyR-BKCa axis.
Arterioscler. Thromb. Vasc. Biol., 2015 Aug , 35 (1843-51).

42

Samour MS et al. Cav3.2-expressing low-threshold C fibres in human hairy skin contribute to cold allodynia--a non-TRPV1- and non-TRPM8-dependent phenomenon.
Pain, 2015 Aug , 156 (1566-75).

43

Fukami K et al. Hydrogen sulfide and neuronal differentiation: focus on Ca2+ channels.
Nitric Oxide, 2015 Apr 30 , 46 (50-4).

44

Tomasova L et al. Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels.
Nitric Oxide, 2015 Apr 30 , 46 (131-44).

45

Staehlke S et al. Intracellular calcium dynamics dependent on defined microtopographical features of titanium.
Biomaterials, 2015 Apr , 46 (48-57).

46

Elíes J et al. Inhibition of T-type Ca(2+) Channels by Hydrogen Sulfide.
Adv. Exp. Med. Biol., 2015 , 860 (353-60).

47

Tang J et al. Chronic hypoxia in pregnancy affected vascular tone of renal interlobar arteries in the offspring.
Sci Rep, 2015 , 5 (9723).

48

Brun J et al. Smooth Muscle-Like Cells Generated from Human Mesenchymal Stromal Cells Display Marker Gene Expression and Electrophysiological Competence Comparable to Bladder Smooth Muscle Cells.
PLoS ONE, 2015 , 10 (e0145153).

49

Terada Y et al. H2S and Pain: A Novel Aspect for Processing of Somatic, Visceral and Neuropathic Pain Signals.
Handb Exp Pharmacol, 2015 , 230 (217-30).

50

Srinivasan PP et al. Inhibition of T-Type Voltage Sensitive Calcium Channel Reduces Load-Induced OA in Mice and Suppresses the Catabolic Effect of Bone Mechanical Stress on Chondrocytes.
PLoS ONE, 2015 , 10 (e0127290).

51

Scholl UI et al. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.
Elife, 2015 , 4 (e06315).

52

Chung NC et al. Behavior training reverses asymmetry in hippocampal transcriptome of the cav3.2 knockout mice.
PLoS ONE, 2015 , 10 (e0118832).

53

van Loo KM et al. Zinc regulates a key transcriptional pathway for epileptogenesis via metal-regulatory transcription factor 1.
Nat Commun, 2015 , 6 (8688).

54

Saito Y et al. Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker.
PLoS ONE, 2015 , 10 (e0138193).

55

Nagi SS et al. The effects of preferential A- and C-fibre blocks and T-type calcium channel antagonist on detection of low-force monofilaments in healthy human participants.
BMC Neurosci, 2015 , 16 (52).

56

Duzhyy DE et al. Upregulation of T-type Ca2+ channels in long-term diabetes determines increased excitability of a specific type of capsaicin-insensitive DRG neurons.
Mol Pain, 2015 , 11 (29).

57

Watanabe M et al. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
PLoS ONE, 2015 , 10 (e0127572).

58

Gadotti VM et al. Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain.
Mol Pain, 2015 , 11 (12).

59

Shen FY et al. Alleviation of neuropathic pain by regulating T-type calcium channels in rat anterior cingulate cortex.
Mol Pain, 2015 , 11 (7).

60

Garcia-Caballero A et al. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity.
Neuron, 2014 Sep 3 , 83 (1144-58).

61

Harraz OF et al. Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries.
Circ. Res., 2014 Sep 12 , 115 (650-61).

62

Chevalier M et al. T-type calcium channels are involved in hypoxic pulmonary hypertension.
Cardiovasc. Res., 2014 Sep 1 , 103 (597-606).

63

Ayoola C et al. Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone.
Psychopharmacology (Berl.), 2014 Sep , 231 (3503-15).

64

Cazade M et al. 5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.
Pflugers Arch., 2014 Sep , 466 (1759-68).

65

Zhang Y et al. Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels.
Sci Signal, 2014 Oct 7 , 7 (ra94).

66

Felizola SJ et al. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
J. Steroid Biochem. Mol. Biol., 2014 Oct , 144 Pt B (410-6).

67

Ranzato E et al. Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels.
Cell Calcium, 2014 Oct , 56 (285-95).

68

Horibe S et al. Ni(2+)-sensitive T-type Ca(2+) channel currents are regulated in parallel with synaptic and visual response plasticity in visual cortex.
Neurosci. Res., 2014 Oct , 87 (33-9).

69

Hu CW et al. Bone morphogenetic protein-4 induces upregulation of Cav3.1 Ca²⁺ channels in HL-1 atrial myocytes.
Pflugers Arch., 2014 Nov , 466 (2049-57).

70

Lin SS et al. Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.
Proc. Natl. Acad. Sci. U.S.A., 2014 May 13 , 111 (E1990-8).

71

González-Ramírez R et al. Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression.
J. Cell. Physiol., 2014 May , 229 (551-60).

72

Perissinotti PP et al. Down-regulation of endogenous KLHL1 decreases voltage-gated calcium current density.
Cell Calcium, 2014 May , 55 (269-80).

73

Lee JH et al. Synthesis and biological evaluation of 1-(isoxazol-5-ylmethylaminoethyl)-4-phenyl tetrahydropyridine and piperidine derivatives as potent T-type calcium channel blockers with antinociceptive effect in a neuropathic pain model.
Eur J Med Chem, 2014 Mar 3 , 74 (246-57).

74

Kuryshev YA et al. Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays.
Assay Drug Dev Technol, 2014 Mar , 12 (110-9).

75

Jarvis MF et al. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Biochem. Pharmacol., 2014 Jun 15 , 89 (536-44).

76

Alday A et al. Ionic channels underlying the ventricular action potential in zebrafish embryo.
Pharmacol. Res., 2014 Jun , 84 (26-31).

77

Tektürk P et al. Calcium channel antibodies in patients with absence epilepsy.
Int. J. Neurosci., 2014 Jul , 124 (486-90).

78

Kerckhove N et al. Cav3.2 calcium channels: the key protagonist of the supraspinal effect of paracetamol.
Pain, 2014 Jan 18 , ().

79

Zaman T et al. LMO4 is essential for paraventricular hypothalamic neuronal activity and calcium channel expression to prevent hyperphagia.
J. Neurosci., 2014 Jan 1 , 34 (140-8).

80

Cui Y et al. Exposure to extremely low-frequency electromagnetic fields inhibits T-type calcium channels via AA/LTE4 signaling pathway.
Cell Calcium, 2014 Jan , 55 (48-58).

81

Sekiguchi F et al. Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells.
Biochem. Biophys. Res. Commun., 2014 Feb 28 , 445 (225-9).

82

Eckle VS et al. Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility.
J. Physiol. (Lond.), 2014 Feb 15 , 592 (795-809).

83

Michaela P et al. Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2014 Feb , 387 (153-63).

84

Powell KL et al. Seizure expression, behavior, and brain morphology differences in colonies of Genetic Absence Epilepsy Rats from Strasbourg.
Epilepsia, 2014 Dec , 55 (1959-68).

85

Elíes J et al. Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels.
FASEB J., 2014 Dec , 28 (5376-87).

86

Thuesen AD et al. Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo.
Am. J. Physiol. Renal Physiol., 2014 Aug 15 , 307 (F445-52).

87

Lee SE et al. Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice.
Proc. Natl. Acad. Sci. U.S.A., 2014 Aug 12 , 111 (11828-33).

88

Riegle MA et al. Ethosuximide reduces electrographical and behavioral correlates of alcohol withdrawal seizure in DBA/2J mice.
Alcohol, 2014 Aug , 48 (445-53).

89

Zheng H et al. Expression and function of a T-type Ca2+ conductance in interstitial cells of Cajal of the murine small intestine.
Am. J. Physiol., Cell Physiol., 2014 Apr 1 , 306 (C705-13).

90

Carbone E et al. T-type channel-mediated neurotransmitter release.
Pflugers Arch., 2014 Apr , 466 (677-87).

91

Kuo IY et al. Role of T-type channels in vasomotor function: team player or chameleon?
Pflugers Arch., 2014 Apr , 466 (767-79).

92

Chemin J et al. Modulation of T-type calcium channels by bioactive lipids.
Pflugers Arch., 2014 Apr , 466 (689-700).

93

Todorovic SM et al. Targeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy.
Pflugers Arch., 2014 Apr , 466 (701-6).

94

Shuba YM Models of calcium permeation through T-type channels.
Pflugers Arch., 2014 Apr , 466 (635-44).

95

Perez-Reyes E et al. Ins and outs of T-channel structure function.
Pflugers Arch., 2014 Apr , 466 (627-33).

96

Gangarossa G et al. T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants.
Front Behav Neurosci, 2014 , 8 (92).

97

Bladen C et al. Block of T-type calcium channels by protoxins I and II.
Mol Brain, 2014 , 7 (36).

98

Tevoufouet EE et al. Cardiac functions of voltage-gated Ca(2+) channels: role of the pharmacoresistant type (E-/R-Type) in cardiac modulation and putative implication in sudden unexpected death in epilepsy (SUDEP).
Rev. Physiol. Biochem. Pharmacol., 2014 , 167 (115-39).

99

Cioli C et al. Differences in human cortical gene expression match the temporal properties of large-scale functional networks.
PLoS ONE, 2014 , 9 (e115913).

100

Berger ND et al. NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.
Mol Pain, 2014 , 10 (77).

101

Obradović ALj et al. CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy.
PLoS ONE, 2014 , 9 (e91467).

102

Elies J et al. OP20 Inhibition of recombinant T-type Ca(2+) channels by hydrogen sulfide.
Nitric Oxide, 2013 Sep 1 , 31 Suppl 2 (S27-8).

103

Wu Z et al. Full-length membrane-bound tumor necrosis factor-α acts through tumor necrosis factor receptor 2 to modify phenotype of sensory neurons.
Pain, 2013 Sep , 154 (1778-82).

104

Uchino T et al. Window current through the T-type Ca2+ channel triggers the mechanism for cellular apoptosis via mitochondrial pathways.
Heart Vessels, 2013 Sep , 28 (658-66).

105

Senadheera S et al. Enhanced contractility in pregnancy is associated with augmented TRPC3, L-type, and T-type voltage-dependent calcium channel function in rat uterine radial artery.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2013 Oct 15 , 305 (R917-26).

106

Demers-Giroux PO et al. Cooperative activation of the T-type CaV3.2 channel: interaction between Domains II and III.
J. Biol. Chem., 2013 Oct 11 , 288 (29281-93).

107

Rose KE et al. Immunohistological demonstration of CaV3.2 T-type voltage-gated calcium channel expression in soma of dorsal root ganglion neurons and peripheral axons of rat and mouse.
Neuroscience, 2013 Oct 10 , 250 (263-74).

108

Lee J et al. Redox mechanism of S-nitrosothiol modulation of neuronal CaV3.2 T-type calcium channels.
Mol. Neurobiol., 2013 Oct , 48 (274-80).

109

Rozanski GM et al. Low voltage-activated calcium channels gate transmitter release at the dorsal root ganglion sandwich synapse.
J. Physiol. (Lond.), 2013 Nov 15 , 591 (5575-83).

110

Hsu SC et al. Early growth response 1 is an early signal inducing Cav3.2 T-type calcium channels during cardiac hypertrophy.
Cardiovasc. Res., 2013 Nov 1 , 100 (222-30).

111

Seo H et al. Effects of eugenol on T-type Ca2+ channel isoforms.
J. Pharmacol. Exp. Ther., 2013 Nov , 347 (310-7).

112

Orestes P et al. Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels.
Diabetes, 2013 Nov , 62 (3828-38).

113

Gouriou Y et al. Mitochondrial Ca2+ uptake from plasma membrane Cav3.2 protein channels contributes to ischemic toxicity in PC12 cells.
J. Biol. Chem., 2013 May 3 , 288 (12459-68).

114

Khomula EV et al. Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy.
Biochim. Biophys. Acta, 2013 May , 1832 (636-49).

115

Nosal OV et al. Complex modulation of Ca(v)3.1 T-type calcium channel by nickel.
Cell. Mol. Life Sci., 2013 May , 70 (1653-61).

116

Yue J et al. Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.
Spine, 2013 Mar 15 , 38 (463-70).

117

Huang CH et al. Physical interaction between calcineurin and Cav3.2 T-type Ca2+ channel modulates their functions.
FEBS Lett., 2013 Jun 19 , 587 (1723-30).

118

Howitt L et al. Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.
Cardiovasc. Res., 2013 Jun 1 , 98 (449-57).

119

Albéri L et al. The calcium-binding protein parvalbumin modulates the firing 1 properties of the reticular thalamic nucleus bursting neurons.
J. Neurophysiol., 2013 Jun , 109 (2827-41).

120

Park HJ et al. Asp residues of the Glu-Glu-Asp-Asp pore filter contribute to ion permeation and selectivity of the Cav3.2 T-type channel.
Cell Calcium, 2013 Jul 9 , ().

121

Engbers JD et al. Modeling interactions between voltage-gated Ca ( 2+) channels and KCa1.1 channels.
Channels (Austin), 2013 Jul 31 , 7 ().

122

Harraz OF et al. Protein kinase A regulation of T-type Ca2+ channels in rat cerebral arterial smooth muscle.
J. Cell. Sci., 2013 Jul 1 , 126 (2944-54).

123

Wan J et al. Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.
Am. J. Physiol. Lung Cell Mol. Physiol., 2013 Jul , 305 (L154-64).

124

Zhang Y et al. Modulation of low-voltage-activated T-type Ca²⁺ channels.
Biochim. Biophys. Acta, 2013 Jul , 1828 (1550-9).

125

Todorovic SM et al. Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling.
Pflugers Arch., 2013 Jul , 465 (921-7).

126

Giordanetto F et al. Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Ca(v)3.2) inhibitor.
Bioorg. Med. Chem. Lett., 2013 Jan 1 , 23 (119-24).

127

Abd El-Rahman RR et al. Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone development.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jan 1 , 304 (H58-71).

128

Kürtüncü M et al. CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL).
Cephalalgia, 2013 Jan , 33 (123-9).

129

Kawabata A [Targeting Ca(v)3.2 T-type calcium channels as a therapeutic strategy for chemotherapy-induced neuropathic pain].
Nippon Yakurigaku Zasshi, 2013 Feb , 141 (81-4).

130

Boycott HE et al. Carbon monoxide inhibition of Cav3.2 T-type Ca2+ channels reveals tonic modulation by thioredoxin.
FASEB J., 2013 Aug , 27 (3395-407).

131

Shan HQ et al. Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.
Alcohol. Clin. Exp. Res., 2013 Aug , 37 (1333-42).

132

Enyeart JJ et al. Ca2+ and K+ channels of normal human adrenal zona fasciculata cells: properties and modulation by ACTH and AngII.
J. Gen. Physiol., 2013 Aug , 142 (137-55).

133

Weiss N et al. Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation.
Pflugers Arch., 2013 Aug , 465 (1159-70).

134

Atkinson AJ et al. Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart.
J Am Heart Assoc, 2013 , 2 (e000246).

135

Sekiguchi F et al. T-type calcium channels: functional regulation and implication in pain signaling.
J. Pharmacol. Sci., 2013 , 122 (244-50).

136

Gadotti VM et al. Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist.
Mol Pain, 2013 , 9 (32).

137

Brennan SC et al. Fetal calcium regulates branching morphogenesis in the developing human and mouse lung: involvement of voltage-gated calcium channels.
PLoS ONE, 2013 , 8 (e80294).

138

Mahapatra S et al. Calcium channel types contributing to chromaffin cell excitability, exocytosis and endocytosis.
Cell Calcium, 2012 Mar-Apr , 51 (321-30).

139

Bladen C et al. Common mechanisms of drug interactions with sodium and T-type calcium channels.
Mol. Pharmacol., 2012 Sep , 82 (481-7).

140

Lopez-Charcas O et al. Block of human CaV3 channels by the diuretic amiloride.
Mol. Pharmacol., 2012 Oct , 82 (658-67).

141

Cui J et al. Expression of CaV3.2 T-type Ca²⁺ channels in a subpopulation of retinal type-3 cone bipolar cells.
Neuroscience, 2012 Nov 8 , 224 (63-9).

142

Francois A et al. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Pain, 2012 Nov 5 , ().

143

van Loo KM et al. Transcriptional regulation of T-type calcium channel CaV3.2: bi-directionality by early growth response 1 (Egr1) and repressor element 1 (RE-1) protein-silencing transcription factor (REST).
J. Biol. Chem., 2012 May 4 , 287 (15489-501).

144

Chevalier M et al. Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels.
, 2012 Mar 3 , ().

145

Tao J et al. Effects of familial hemiplegic migraine type 1 mutation T666M on voltage-gated calcium channel activities in trigeminal ganglion neurons.
J. Neurophysiol., 2012 Mar , 107 (1666-80).

146

Balderas E et al. Niflumic acid blocks native and recombinant T-type channels.
J. Cell. Physiol., 2012 Jun , 227 (2542-55).

147

Gönczi M et al. Age-dependent changes in ion channel mRNA expression in canine cardiac tissues.
Gen. Physiol. Biophys., 2012 Jun , 31 (153-62).

148

Jacus MO et al. Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons.
J. Neurosci., 2012 Jul 4 , 32 (9374-82).

149

Mor M et al. ZnT-1 enhances the activity and surface expression of T-type calcium channels through activation of Ras-ERK signaling.
Am. J. Physiol., Cell Physiol., 2012 Jul 15 , 303 (C192-203).

150

Li CX et al. [Distribution diversity of integrins and calcium channels on major human and mouse host cells of Leptospira species].
Zhejiang Da Xue Xue Bao Yi Xue Ban, 2012 Jul , 41 (410-7).

151

Ohkubo T et al. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.
Int. J. Oncol., 2012 Jul , 41 (267-75).

152

Okubo K et al. Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice.
Br. J. Pharmacol., 2012 Jul , 166 (1738-43).

153

Weiss N et al. A Ca(v)3.2/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis.
J. Biol. Chem., 2012 Jan 20 , 287 (2810-8).

154

Zhang Y et al. Inhibition of T-type Ca(2+) channels by endostatin attenuates human glioblastoma cell proliferation and migration.
, 2012 Jan 10 , ().

155

Bolaños-Jiménez R et al. Mice mechanoreceptors are modulated by Ca(v)3.2 T-type calcium channels.
J. Physiol. (Lond.), 2012 Jan 1 , 590 (7).

156

Hilaire C et al. Neurotrophin-4 modulates the mechanotransducer Cav3.2 T-type calcium current in mice down-hair neurons.
Biochem. J., 2012 Jan 1 , 441 (463-71).

157

Engbers JD et al. Intermediate conductance calcium-activated potassium channels modulate summation of parallel fiber input in cerebellar Purkinje cells.
Proc. Natl. Acad. Sci. U.S.A., 2012 Feb 14 , 109 (2601-6).

158

Matsunami M et al. Hydrogen sulfide-induced colonic mucosal cytoprotection involves T-type calcium channel-dependent neuronal excitation in rats.
J. Physiol. Pharmacol., 2012 Feb , 63 (61-8).

159

Schweikart K et al. The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity.
Toxicol In Vitro, 2012 Dec 20 , 27 (745-751).

160

Tzeng BH et al. The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.
Cardiovasc. Res., 2012 Dec 1 , 96 (533-42).

161

Chen CC et al. Retrieval of context-associated memory is dependent on the Ca(v)3.2 T-type calcium channel.
PLoS ONE, 2012 , 7 (e29384).

162

Tsubota-Matsunami M et al. Colonic hydrogen sulfide-induced visceral pain and referred hyperalgesia involve activation of both Ca(v)3.2 and TRPA1 channels in mice.
J. Pharmacol. Sci., 2012 , 119 (293-6).

163

Li Y et al. β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A.
PLoS ONE, 2012 , 7 (e39965).

164

Giordanetto F et al. Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors.
Bioorg. Med. Chem. Lett., 2011 Sep 15 , 21 (5557-61).

165

Thompson WR et al. Association of the α(2)δ(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes.
J. Bone Miner. Res., 2011 Sep , 26 (2125-39).

166

Howarth FC et al. Contractility of ventricular myocytes is well preserved despite altered mechanisms of Ca(2+) transport and a changing pattern of mRNA in aged type 2 Zucker diabetic fatty rat heart.
, 2011 Oct 19 , ().

167

Bahrudin U et al. Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction.
J. Mol. Biol., 2011 Nov 4 , 413 (857-78).

168

Rodriguez-Gomez JA et al. T-type Ca2+ channels in mouse embryonic stem cells: modulation during cell cycle and contribution to self-renewal.
, 2011 Nov 2 , ().

169

Cao XH et al. Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons.
J. Neurochem., 2011 Nov , 119 (594-603).

170

Choe W et al. TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.
Mol. Pharmacol., 2011 Nov , 80 (900-10).

171

Enyeart JA et al. 8-Phenylthio-adenines stimulate the expression of steroid hydroxylases, Cav3.2 Ca²⁺ channels, and cortisol synthesis by a cAMP-independent mechanism.
Am. J. Physiol. Endocrinol. Metab., 2011 Nov , 301 (E941-54).

172

Alnawaiseh M et al. Two separate Ni(2+) -sensitive voltage-gated Ca(2+) channels modulate transretinal signalling in the isolated murine retina.
Acta Ophthalmol, 2011 Nov , 89 (e579-90).

173

Inayoshi A et al. Mechanism underlying the block of human Cav3.2 T-type Ca2+ channels by benidipine, a dihydropyridine Ca2+ channel blocker.
Life Sci., 2011 May 9 , 88 (898-907).

174

Matsunami M et al. Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels.
Neuroscience, 2011 May 5 , 181 (257-64).

175

Wang R et al. The Cav3.2 T-type calcium channel regulates temporal coding in mouse mechanoreceptors.
J. Physiol. (Lond.), 2011 May 1 , 589 (2229-43).

176

Howarth FC et al. Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca2+ signalling in young type 2 Zucker diabetic fatty rat heart.
Exp. Physiol., 2011 Mar , 96 (325-37).

177

Marger F et al. T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome.
Proc. Natl. Acad. Sci. U.S.A., 2011 Jul 5 , 108 (11268-73).

178

Huang Z et al. Presynaptic HCN1 channels regulate Ca(V)3.2 activity and neurotransmission at select cortical synapses.
, 2011 Feb 27 , ().

179

Hildebrand ME et al. A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain.
, 2011 Feb 22 , ().

180

Poulsen CB et al. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
Kidney Int., 2011 Feb , 79 (443-51).

181

Hill J et al. Pituitary adenylate cyclase-activating peptide (PACAP) recruits low voltage-activated T-type calcium influx under acute sympathetic stimulation in mouse adrenal chromaffin cells.
J. Biol. Chem., 2011 Dec 9 , 286 (42459-69).

182

Yalçın O Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies.
, 2011 Dec 27 , ().

183

Liu G et al. [Regulation of T-type Ca(2+) channel in lysophosphatidylcholine-stimulated cardiomyocytes].
Beijing Da Xue Xue Bao, 2011 Dec 18 , 43 (804-8).

184

Lacinová L T-type calcium channel blockers - new and notable.
Gen. Physiol. Biophys., 2011 Dec , 30 (403-9).

185

Astori S et al. The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus.
Proc. Natl. Acad. Sci. U.S.A., 2011 Aug 16 , 108 (13823-8).

186

Okubo K et al. Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats.
Neuroscience, 2011 Aug 11 , 188 (148-56).

187

Le Quang K et al. Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice.
Cardiovasc. Res., 2011 Aug 1 , 91 (420-8).

188

Lei D et al. Anti-epileptic drugs delay age-related loss of spiral ganglion neurons via T-type calcium channel.
Hear. Res., 2011 Aug , 278 (106-12).

189

Wang Q et al. Effects of raloxifene on voltage-dependent T-type Ca2+ channels in mouse spermatogenic cells.
Pharmacology, 2011 , 87 (70-80).

190

Liao YF et al. Involvement of the Cav3.2 T-type calcium channel in thalamic neuron discharge patterns.
Mol Pain, 2011 , 7 (43).

191

You H et al. Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands.
Mol Pain, 2011 , 7 (89).

192

David LS et al. Splice-variant changes of the Ca(V)3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development.
Channels (Austin), 2010 Sep-Oct , 4 (375-89).

193

Cribbs L T-type calcium channel expression and function in the diseased heart.
Channels (Austin), 2010 Nov-Dec , 4 (447-52).

194

Cain SM et al. Contributions of T-type calcium channel isoforms to neuronal firing.
Channels (Austin), 2010 Nov-Dec , 4 (475-82).

195

Perez-Reyes E Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.
Channels (Austin), 2010 Nov-Dec , 4 (453-8).

196

Anderson D et al. Regulation of the KV4.2 complex by CaV3.1 calcium channels.
Channels (Austin), 2010 May-Jun , 4 (163-7).

197

Orestes P et al. Free radical signaling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway.
, 2010 Nov 8 , ().

198

Markandeya YS et al. Caveolin-3 regulates the protein kinase A modulation of CaV3.2 ({alpha}1H) T-type Ca2+ channels.
, 2010 Nov 17 , ().

199

Ou Y et al. Expression of key ion channels in the rat cardiac conduction system by laser capture microdissection and qPCR.
, 2010 May 28 , ().

200

Prigge M et al. Fast, repetitive light-activation of Ca(V)3.2 using channelrhodopsin 2.
, 2010 May 25 , 4 ().

201

Strege PR et al. T-type Ca(2+) channel modulation by otilonium bromide.
Am. J. Physiol. Gastrointest. Liver Physiol., 2010 May , 298 (G706-13).

202

Thévenod F Catch me if you can! Novel aspects of cadmium transport in mammalian cells.
, 2010 Mar 5 , ().

203

Liu H et al. ACTH induces Cav3.2 current and mRNA by cAMP-dependent and cAMP-independent mechanisms.
J. Biol. Chem., 2010 Jun 25 , 285 (20040-50).

204

Aromolaran KA et al. T-type current modulation by the actin-binding protein Kelch-like 1.
Am. J. Physiol., Cell Physiol., 2010 Jun , 298 (C1353-62).

205

Kuo IY et al. Dihydropyridine-insensitive calcium currents contribute to function of small cerebral arteries.
J. Cereb. Blood Flow Metab., 2010 Jun , 30 (1226-39).

206

Omatsu-Kanbe M et al. Self-beating atypically shaped cardiomyocytes survive a long-term postnatal development while preserving the expression of fetal cardiac genes in mice.
J. Histochem. Cytochem., 2010 Jun , 58 (543-51).

207

Tarui T et al. Involvement of Src kinase in T-type calcium channel-dependent neuronal differentiation of NG108-15 cells by hydrogen sulfide.
J. Neurochem., 2010 Jul , 114 (512-9).

208

Takahashi T et al. Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.
Pain, 2010 Jul , 150 (183-91).

209

Kang HW et al. Structural determinants of the high affinity extracellular zinc binding site on Cav3.2 T-type calcium channels.
J. Biol. Chem., 2010 Jan 29 , 285 (3271-81).

210

Zheng M et al. Intracellular Ca(2+)- and PKC-dependent upregulation of T-type Ca(2+) channels in LPC-stimulated cardiomyocytes.
J. Mol. Cell. Cardiol., 2010 Jan , 48 (131-9).

211

Ono K et al. Cardiac T-type Ca(2+) channels in the heart.
J. Mol. Cell. Cardiol., 2010 Jan , 48 (65-70).

212

You H et al. CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels.
Mol. Pharmacol., 2010 Feb , 77 (211-7).

213

Perez-Reyes E G protein-mediated inhibition of Cav3.2 T-type channels revisited.
Mol. Pharmacol., 2010 Feb , 77 (136-8).

214

Rangel A et al. Protein kinase C-mediated inhibition of recombinant T-type Cav3.2 channels by neurokinin 1 receptors.
Mol. Pharmacol., 2010 Feb , 77 (202-10).

215

Chen WK et al. Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain.
J. Neurosci., 2010 Aug 4 , 30 (10360-8).

216

Souvannakitti D et al. NADPH oxidase-dependent regulation of T-type Ca2+ channels and ryanodine receptors mediate the augmented exocytosis of catecholamines from intermittent hypoxia-treated neonatal rat chromaffin cells.
J. Neurosci., 2010 Aug 11 , 30 (10763-72).

217

Smith EM et al. T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis.
Bioorg. Med. Chem. Lett., 2010 Aug 1 , 20 (4602-6).

218

Liang H et al. Electrophysiological basis of the first heart beats.
Cell. Physiol. Biochem., 2010 , 25 (561-70).

219

Wen XJ et al. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Pharmacology, 2010 , 85 (295-300).

220

Mizuta E et al. Different distribution of Cav3.2 and Cav3.1 transcripts encoding T-type Ca(2+) channels in the embryonic heart of mice.
Biomed. Res., 2010 , 31 (301-5).

221

Gibbons SJ et al. The alpha1H Ca2+ channel subunit is expressed in mouse jejunal interstitial cells of Cajal and myocytes.
J. Cell. Mol. Med., 2009 Nov-Dec , 13 (4422-31).

222

Barbara G et al. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
J. Neurosci., 2009 Oct 21 , 29 (13106-14).

223

Braun AP Convergent signaling events underlie dopamine-mediated inhibition of CaV3.2 T-type calcium channels.
Channels (Austin), 2009 Nov , 3 (381-2).

224

Lewis BB et al. Cloning and characterization of voltage-gated calcium channel alpha1 subunits in Xenopus laevis during development.
Dev. Dyn., 2009 Nov , 238 (2891-902).

225

Aromolaran KA et al. Kelch-like 1 protein upregulates T-type currents by an actin-F dependent increase in α(1H) channels via the recycling endosome.
Channels (Austin), 2009 Nov , 3 (402-12).

226

Hu C et al. Protein kinase A activity controls the regulation of T-type CaV3.2 channels by Gbetagamma dimers.
J. Biol. Chem., 2009 Mar 20 , 284 (7465-73).

227

Maeda Y et al. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
Pain, 2009 Mar , 142 (127-32).

228

Somekawa S et al. Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor.
Endocrinology, 2009 Jul , 150 (3110-7).

229

Bosch MA et al. 17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta.
J. Comp. Neurol., 2009 Jan 20 , 512 (347-58).

230

Masuda T et al. Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.
Brain Res., 2009 Jan 16 , 1249 (61-7).

231

Powell KL et al. A Cav3.2 T-type calcium channel point mutation has splice-variant-specific effects on function and segregates with seizure expression in a polygenic rat model of absence epilepsy.
J. Neurosci., 2009 Jan 14 , 29 (371-80).

232

Jensen LJ et al. Is there a role for T-type Ca2+ channels in regulation of vasomotor tone in mesenteric arterioles?
Can. J. Physiol. Pharmacol., 2009 Jan , 87 (8-20).

233

Tao J et al. Tyrosine kinase-independent inhibition by genistein on spermatogenic T-type calcium channels attenuates mouse sperm motility and acrosome reaction.
Cell Calcium, 2009 Feb , 45 (133-43).

234

Perez-Reyes E et al. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
J. Pharmacol. Exp. Ther., 2009 Feb , 328 (621-7).

235

Koyama T et al. Molecular and electrical remodeling of L- and T-type Ca(2+) channels in rat right atrium with monocrotaline-induced pulmonary hypertension.
Circ. J., 2009 Feb , 73 (256-63).

236

Wu ZZ et al. Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit.
J. Biol. Chem., 2009 Dec 25 , 284 (36453-61).

237

Zamponi GW et al. Role of voltage-gated calcium channels in epilepsy.
, 2009 Dec 20 , ().

238

Zhang C et al. 17Beta-estradiol regulation of T-type calcium channels in gonadotropin-releasing hormone neurons.
J. Neurosci., 2009 Aug 26 , 29 (10552-62).

239

Maturana A et al. Role of the T-type calcium channel CaV3.2 in the chronotropic action of corticosteroids in isolated rat ventricular myocytes.
Endocrinology, 2009 Aug , 150 (3726-34).

240

Mulgrew CJ et al. Inhibition of human mesangial cell proliferation by targeting T-type calcium channels.
Nephron Exp. Nephrol., 2009 , 113 (e77-88).

241

Inagaki A et al. The CaV3.1 T-type Ca2+channel contributes to voltage-dependent calcium currents in rat outer hair cells.
Brain Res., 2008 Mar 27 , 1201 (68-77).

242

Varela DL et al. Making the T-type even tinier: corticotropin-releasing factor-mediated inhibition of low-voltage-activated calcium channel activity.
Mol. Pharmacol., 2008 Jun , 73 (1589-91).

243

Tao J et al. Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels.
Mol. Pharmacol., 2008 Jun , 73 (1596-609).

244

Strube C Absence of regulation of the T-type calcium current by Cav1.1, beta1a and gamma1 dihydropyridine receptor subunits in skeletal muscle cells.
Pflugers Arch., 2008 Feb , 455 (921-7).

245

Huh SU et al. Regulation of CA(v)3.2 Ca2+ channel activity by protein tyrosine phosphorylation.
J. Microbiol. Biotechnol., 2008 Feb , 18 (365-8).

246

Becker AJ et al. Transcriptional upregulation of Cav3.2 mediates epileptogenesis in the pilocarpine model of epilepsy.
J. Neurosci., 2008 Dec 3 , 28 (13341-53).

247

Kang HW et al. Distinct contributions of different structural regions to the current kinetics of the Cav3.3 T-type Ca2+ channel.
Biochim. Biophys. Acta, 2008 Dec , 1778 (2740-8).

248

Gackière F et al. CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells.
J. Biol. Chem., 2008 Apr 11 , 283 (10162-73).

249

Aptel H et al. The Cav3.2/alpha1H T-type Ca2+ current is a molecular determinant of excitatory effects of GABA in adult sensory neurons.
Mol. Cell. Neurosci., 2007 Oct , 36 (293-303).

250

Liang J et al. Common polymorphisms in the CACNA1H gene associated with childhood absence epilepsy in Chinese Han population.
Ann. Hum. Genet., 2007 May , 71 (325-35).

251

Blanks AM et al. Characterization of the molecular and electrophysiological properties of the T-type calcium channel in human myometrium.
J. Physiol. (Lond.), 2007 Jun 15 , 581 (915-26).

252

Hildebrand ME et al. Selective inhibition of Cav3.3 T-type calcium channels by Galphaq/11-coupled muscarinic acetylcholine receptors.
J. Biol. Chem., 2007 Jul 20 , 282 (21043-55).

253

Vitko I et al. The I-II loop controls plasma membrane expression and gating of Ca(v)3.2 T-type Ca2+ channels: a paradigm for childhood absence epilepsy mutations.
J. Neurosci., 2007 Jan 10 , 27 (322-30).

254

Traboulsie A et al. Subunit-specific modulation of T-type calcium channels by zinc.
J. Physiol. (Lond.), 2007 Jan 1 , 578 (159-71).

255

Coste B et al. Pharmacological dissection and distribution of NaN/Nav1.9, T-type Ca2+ currents, and mechanically activated cation currents in different populations of DRG neurons.
J. Gen. Physiol., 2007 Jan , 129 (57-77).

256

Kang HW et al. Histidine residues in the IS3-IS4 loop are critical for nickel-sensitive inhibition of the Cav2.3 calcium channel.
FEBS Lett., 2007 Dec 22 , 581 (5774-80).

257

Heron SE et al. Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants.
Ann. Neurol., 2007 Dec , 62 (560-8).

258

Sun HS et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J., 2007 Aug 15 , 93 (1175-83).

259

Asaga S et al. Identification of a new breast cancer-related gene by restriction landmark genomic scanning.
Anticancer Res., 2006 Jan-Feb , 26 (35-42).

260

Nordskog BK et al. Diurnal gene expression patterns of T-type calcium channels and their modulation by ethanol.
Neuroscience, 2006 Sep 1 , 141 (1365-73).

261

Mathie A et al. Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability.
Pharmacol. Ther., 2006 Sep , 111 (567-83).

262

Liang J et al. New variants in the CACNA1H gene identified in childhood absence epilepsy.
Neurosci. Lett., 2006 Oct 2 , 406 (27-32).

263

Avila T et al. Transforming growth factor-beta1 and bone morphogenetic protein-2 downregulate CaV3.1 channel expression in mouse C2C12 myoblasts.
J. Cell. Physiol., 2006 Nov , 209 (448-56).

264

Zhong X et al. A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies.
Hum. Mol. Genet., 2006 May 1 , 15 (1497-512).

265

Chioza B et al. Evaluation of CACNA1H in European patients with childhood absence epilepsy.
Epilepsy Res., 2006 May , 69 (177-81).

266

Yamashita N et al. Short- and long-term amiodarone treatments regulate Cav3.2 low-voltage-activated T-type Ca2+ channel through distinct mechanisms.
Mol. Pharmacol., 2006 May , 69 (1684-91).

267

Giancippoli A et al. Low-threshold exocytosis induced by cAMP-recruited CaV3.2 (alpha1H) channels in rat chromaffin cells.
Biophys. J., 2006 Mar 1 , 90 (1830-41).

268

Bergh JJ et al. Osteoblast Ca(2+) permeability and voltage-sensitive Ca(2+) channel expression is temporally regulated by 1,25-dihydroxyvitamin D(3).
Am. J. Physiol., Cell Physiol., 2006 Mar , 290 (C822-31).

269

Peloquin JB et al. Functional analysis of Ca3.2 T-type calcium channel mutations linked to childhood absence epilepsy.
Epilepsia, 2006 Mar , 47 (655-8).

270

Joksovic PM et al. CaV3.2 is the major molecular substrate for redox regulation of T-type Ca2+ channels in the rat and mouse thalamus.
J. Physiol. (Lond.), 2006 Jul 15 , 574 (415-30).

271

Kim JA et al. Augmentation of Cav3.2 T-type calcium channel activity by cAMP-dependent protein kinase A.
J. Pharmacol. Exp. Ther., 2006 Jul , 318 (230-7).

272

Kang HW et al. A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels.
J. Biol. Chem., 2006 Feb 24 , 281 (4823-30).

273

Mizuta E et al. Delayed onset of beating and decreased expression of T-type Ca2+ channel in mouse ES cell-derived cardiocytes carrying human chromosome 21.
Biochem. Biophys. Res. Commun., 2006 Dec 8 , 351 (126-32).

274

Park JY et al. Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density.
J. Physiol. (Lond.), 2006 Dec 1 , 577 (513-23).

275

Wen XJ et al. Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion.
Acta Pharmacol. Sin., 2006 Dec , 27 (1547-52).

276

Perez-Reyes E et al. Molecular biology of T-type calcium channels.
CNS Neurol Disord Drug Targets, 2006 Dec , 5 (605-9).

277

Lambert RC et al. Modulation of neuronal T-type calcium channels.
CNS Neurol Disord Drug Targets, 2006 Dec , 5 (611-27).

278

Splawski I et al. CACNA1H mutations in autism spectrum disorders.
J. Biol. Chem., 2006 Aug 4 , 281 (22085-91).

279

Perez-Reyes E Molecular characterization of T-type calcium channels.
Cell Calcium, 2006 Aug , 40 (89-96).

280

Talavera K et al. Biophysics and structure-function relationship of T-type Ca2+ channels.
Cell Calcium, 2006 Aug , 40 (97-114).

281

Lory P et al. T-type calcium channels in differentiation and proliferation.
Cell Calcium, 2006 Aug , 40 (135-46).

282

Chemin J et al. Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones.
Cell Calcium, 2006 Aug , 40 (121-34).

283

Wang JL et al. [The effect of CACNA1H gene G773D mutation on calcium channel function]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006 Aug , 23 (369-73).

284

Shao Y et al. Expression of voltage sensitive calcium channel (VSCC) L-type Cav1.2 (alpha1C) and T-type Cav3.2 (alpha1H) subunits during mouse bone development.
Dev. Dyn., 2005 Sep , 234 (54-62).

285

Mulley JC et al. Susceptibility genes for complex epilepsy.
Hum. Mol. Genet., 2005 Oct 15 , 14 Spec No. 2 (R243-9).

286

Mizuta E et al. Subtype switching of T-type Ca 2+ channels from Cav3.2 to Cav3.1 during differentiation of embryonic stem cells to cardiac cell lineage.
Circ. J., 2005 Oct , 69 (1284-9).

287

Kuwahara K et al. Pathophysiological significance of T-type Ca2+ channels: transcriptional regulation of T-type Ca2+ channel--regulation of CACNA1H by neuron-restrictive silencer factor.
J. Pharmacol. Sci., 2005 Nov , 99 (211-3).

288

Vitko I et al. Functional characterization and neuronal modeling of the effects of childhood absence epilepsy variants of CACNA1H, a T-type calcium channel.
J. Neurosci., 2005 May 11 , 25 (4844-55).

289

Khosravani H et al. Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy.
Ann. Neurol., 2005 May , 57 (745-9).

290

Uchino T et al. Voltage-dependent and frequency-independent inhibition of recombinant Cav3.2 T-type Ca2+ channel by bepridil.
Pharmacology, 2005 Jul , 74 (174-81).

291

Bourinet E et al. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception.
EMBO J., 2005 Jan 26 , 24 (315-24).

292

Larsen JK et al. Disruption of growth hormone secretion alters Ca2+ current density and expression of Ca2+ channel and insulin-like growth factor genes in rat atria.
Am. J. Physiol. Heart Circ. Physiol., 2005 Feb , 288 (H829-38).

293

Brueggemann LI et al. Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking.
Am. J. Physiol. Heart Circ. Physiol., 2005 Feb , 288 (H923-35).

294

Lu JJ et al. [T-type calcium channel gene-CACNA1H is a susceptibility gene to childhood absence epilepsy]
Zhonghua Er Ke Za Zhi, 2005 Feb , 43 (133-6).

295

Autret L et al. The involvement of Cav3.2/alpha1H T-type calcium channels in excitability of mouse embryonic primary vestibular neurones.
J. Physiol. (Lond.), 2005 Aug 15 , 567 (67-78).

296

Gardiner M Genetics of idiopathic generalized epilepsies.
Epilepsia, 2005 , 46 Suppl 9 (15-20).

297

Khosravani H et al. Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy.
J. Biol. Chem., 2004 Mar 12 , 279 (9681-4).

298

Niwa N et al. Cav3.2 subunit underlies the functional T-type Ca2+ channel in murine hearts during the embryonic period.
Am. J. Physiol. Heart Circ. Physiol., 2004 Jun , 286 (H2257-63).

299

Stamboulian S et al. Biophysical and pharmacological characterization of spermatogenic T-type calcium current in mice lacking the CaV3.1 (alpha1G) calcium channel: CaV3.2 (alpha1H) is the main functional calcium channel in wild-type spermatogenic cells.
J. Cell. Physiol., 2004 Jul , 200 (116-24).

300

Gray LS et al. The role of voltage gated T-type Ca2+ channel isoforms in mediating "capacitative" Ca2+ entry in cancer cells.
Cell Calcium, 2004 Dec , 36 (489-97).

301

Yoshida M et al. Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells.
Blood, 2004 Apr 1 , 103 (2753-60).

302

Heron SE et al. Genetic variation of CACNA1H in idiopathic generalized epilepsy.
Ann. Neurol., 2004 Apr , 55 (595-6).

303

Welsby PJ et al. A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II.
J. Neurosci., 2003 Nov 5 , 23 (10116-21).

304

Delisle BP et al. Monovalent cations contribute to T-type calcium channel (Cav3.1 and Cav3.2) selectivity.
J. Membr. Biol., 2003 Jun 1 , 193 (185-94).

305

Kaku T et al. The gating and conductance properties of Cav3.2 low-voltage-activated T-type calcium channels.
Jpn. J. Physiol., 2003 Jun , 53 (165-72).

306

Perez-Reyes E Molecular physiology of low-voltage-activated t-type calcium channels.
Physiol. Rev., 2003 Jan , 83 (117-61).

307

Ferron L et al. Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.
Circ. Res., 2003 Dec 12 , 93 (1241-8).

308

Yunker AM et al. Low-voltage-activated ("T-Type") calcium channels in review.
J. Bioenerg. Biomembr., 2003 Dec , 35 (533-75).

309

Chen Y et al. Association between genetic variation of CACNA1H and childhood absence epilepsy.
Ann. Neurol., 2003 Aug , 54 (239-43).

310

Chemin J et al. [Functional specificity of T-type calcium channels and their roles in neuronal differentiation]
J. Soc. Biol., 2003 , 197 (235-47).

311

Mariot P et al. Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells.
J. Biol. Chem., 2002 Mar 29 , 277 (10824-33).

312

Zhang Y et al. Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons.
J. Neurosci., 2002 Aug 1 , 22 (6362-71).

313

Wang YQ et al. [Functional analysis of the human T-type calcium channel alpha 1H subunit gene in cellular proliferation]
Yi Chuan Xue Bao, 2002 , 29 (659-65).

314

Kushmerick C et al. Changes in Ca(2+) channel expression upon differentiation of SN56 cholinergic cells.
Brain Res., 2001 Oct 19 , 916 (199-210).

315

Perez-Reyes E et al. Molecular characterization of two members of the T-type calcium channel family.
Ann. N. Y. Acad. Sci., 1999 Apr 30 , 868 (131-43).

316

Cribbs LL et al. Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family.
Circ. Res., 1998 Jul 13 , 83 (103-9).